Gilkey Melissa B, Calo William A, Moss Jennifer L, Shah Parth D, Marciniak Macary W, Brewer Noel T
Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, 133 Brookline Ave., Boston, MA 02215, USA.
Department of Health Policy and Management, University of North Carolina, CB 7411, Chapel Hill, NC 27599, USA.
Vaccine. 2016 Feb 24;34(9):1187-92. doi: 10.1016/j.vaccine.2016.01.023. Epub 2016 Jan 24.
Receiving a healthcare provider's recommendation is a strong predictor of HPV vaccination, but little is known empirically about which types of recommendation are most influential. Thus, we sought to investigate the relationship between recommendation quality and HPV vaccination among U.S. adolescents.
In 2014, we conducted a national, online survey of 1495 parents of 11-17-year-old adolescents. Parents reported whether providers endorsed HPV vaccination strongly, encouraged same-day vaccination, and discussed cancer prevention. Using an index of these quality indicators, we categorized parents as having received no, low-quality, or high-quality recommendations for HPV vaccination. Separate multivariable logistic regression models assessed associations between recommendation quality and HPV vaccine initiation (≥ 1 dose), follow through (3 doses, among initiators), refusal, and delay.
Almost half (48%) of parents reported no provider recommendation for HPV vaccination, while 16% received low-quality recommendations and 36% received high-quality recommendations. Compared to no recommendation, high-quality recommendations were associated with over nine times the odds of HPV vaccine initiation (23% vs. 74%, OR=9.31, 95% CI, 7.10-12.22) and over three times the odds of follow through (17% vs. 44%, OR=3.82, 95% CI, 2.39-6.11). Low-quality recommendations were more modestly associated with initiation (OR=4.13, 95% CI, 2.99-5.70), but not follow through. Parents who received high- versus low-quality recommendations less often reported HPV vaccine refusal or delay.
High-quality recommendations were strongly associated with HPV vaccination behavior, but only about one-third of parents received them. Interventions are needed to improve not only whether, but how providers recommend HPV vaccination for adolescents.
获得医疗服务提供者的建议是HPV疫苗接种的一个有力预测因素,但对于哪种类型的建议最具影响力,从实证角度了解甚少。因此,我们试图调查美国青少年中建议质量与HPV疫苗接种之间的关系。
2014年,我们对1495名11至17岁青少年的家长进行了一项全国性在线调查。家长们报告医疗服务提供者是否强烈支持HPV疫苗接种、是否鼓励当日接种以及是否讨论了癌症预防。利用这些质量指标的一个指数,我们将家长分为未收到HPV疫苗接种建议、收到低质量建议或高质量建议的类别。单独的多变量逻辑回归模型评估了建议质量与HPV疫苗开始接种(≥1剂)、全程接种(在开始接种者中接种3剂)、拒绝接种和延迟接种之间的关联。
近一半(48%)的家长报告未收到医疗服务提供者关于HPV疫苗接种的建议,而16%的家长收到低质量建议,36%的家长收到高质量建议。与未收到建议相比,高质量建议与HPV疫苗开始接种的几率高出九倍多(23%对74%,比值比=9.31,95%置信区间,7.10 - 12.22)以及全程接种的几率高出三倍多(17%对44%,比值比=3.82,95%置信区间,2.39 - 6.11)相关。低质量建议与开始接种的关联较为适度(比值比=4.13,95%置信区间,2.99 - 5.70),但与全程接种无关。收到高质量建议与低质量建议的家长较少报告HPV疫苗拒绝接种或延迟接种情况。
高质量建议与HPV疫苗接种行为密切相关,但只有约三分之一的家长收到了此类建议。不仅需要干预措施来改善医疗服务提供者是否建议青少年接种HPV疫苗,还需要改善如何进行建议。